Atlas Trials

Hereditary Hemorrhagic Telangiectasia (HHT)

15 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Hereditary Hemorrhagic Telangiectasia (HHT)

RecordFirmDate
Topical TOR-582 Treatment of Epistaxis in HHT (NCT07667413)Columbia University2026-10-01
Harmony-HHT: ATV-1601 in Participants With Hereditary Hemorrhagic Telangiectasia (HHT) (NCT07601425)Atavistik Bio, Inc2026-07-27
A Trial of TER-1754 in Patients With Hereditary Hemorrhagic Telangiectasia (NCT07255846)Terremoto Biosciences Inc.2025-12-15
Efficacy and Tolerance of Treatment With Bevacizumab for Severe Liver Involvement With High Cardiac Output in Hereditary Hemorrhagic Telangiectasia Within the French Hereditary Hemorrhagic Telangiectasia Network (NCT07445347)Poitiers University Hospital2025-10-15
Description of the Impact of Symptoms on Quality of Life in HHT Disease: DISQUO (NCT07191639)Hospices Civils de Lyon2024-12-01
Pomalidomide for the Treatment of Bleeding in Hereditary Hemorrhagic Telangiectasia Longitudinal Assessment Study (NCT07018401)Massachusetts General Hospital2024-05-01
Assess Safety and Efficacy of VAD044 in HHT Patients (NCT05406362)Vaderis Therapeutics AG2022-07-18
Doxycycline for Hereditary Hemorrhagic Telangiectasia (NCT03397004)Unity Health Toronto2018-09-12
Graded TTCE for Post-Embolization PAVM Monitoring (NCT02936349)University of Pennsylvania2016-10-01
Prospective Pilot Study of Floseal for the Treatment of Anterior Epistaxis in Patients With (HHT) (NCT02638012)Unity Health Toronto2015-12-01
Frequency of Common Medical Conditions in People With and Without HHT (NCT02464644)Imperial College London2012-04-01
Ranibizumab for the Management of Recurrent Nosebleeds in Patients With Hereditary Hemorrhagic Telangiectasia (HHT) (NCT01406639)University of California, San Diego2011-07-01
Submucosal Bevacizumab for the Management of Recurrent Epistaxis in Patients With Hereditary Hemorrhagic Telangiectasia (HHT) (NCT01402531)University of California, San Diego2010-07-22
Topical Bevacizumab for the Management of Recurrent Epistaxis in Patients With Hereditary Hemorrhagic Telangiectasia (HHT) (NCT01397695)University of California, San Diego2009-06-01
IV Bevacizumab Treatment of Patients With Hereditary Hemorrhagic Telangiectasia (HHT) or Rendu-Osler (RO) Disease: A Retrospective Analysis of French Cohort Data From 2009 to 2024 (NCT07772050)Hospices Civils de Lyon2009-01-01

Track Hereditary Hemorrhagic Telangiectasia (HHT) automatically

Every clearance here is in the API, with alerts when new ones post.